细胞毒性T细胞
抗原
免疫学
T细胞
中心公差
CD8型
免疫耐受
细胞生物学
生物
免疫系统
遗传学
体外
作者
Julia F. May,Rees G. Kelly,Alexander Y. W. Suen,J I Kim,Jeongwoo Kim,Colin C. Anderson,Gina R. Rayat,Troy A. Baldwin
出处
期刊:Journal of Immunology
[The American Association of Immunologists]
日期:2023-11-20
卷期号:212 (2): 271-283
被引量:3
标识
DOI:10.4049/jimmunol.2200775
摘要
Highly self-reactive T cells are censored from the repertoire by both central and peripheral tolerance mechanisms upon receipt of high-affinity TCR signals. Clonal deletion is considered a major driver of central tolerance; however, other mechanisms such as induction of regulatory T cells and functional impairment have been described. An understanding of the interplay between these different central tolerance mechanisms is still lacking. We previously showed that impaired clonal deletion to a model tissue-restricted Ag did not compromise tolerance. In this study, we determined that murine T cells that failed clonal deletion were rendered functionally impaired in the thymus. Programmed cell death protein 1 (PD-1) was induced in the thymus and was required to establish cell-intrinsic tolerance to tissue-restricted Ag in CD8+ thymocytes independently of clonal deletion. In bone marrow chimeras, tolerance was not observed in PD-L1-deficient recipients, but tolerance was largely maintained following adoptive transfer of tolerant thymocytes or T cells to PD-L1-deficient recipients. However, CRISPR-mediated ablation of PD-1 in tolerant T cells resulted in broken tolerance, suggesting different PD-1 signaling requirements for establishing versus maintaining tolerance. Finally, we showed that chronic exposure to high-affinity Ag supported the long-term maintenance of tolerance. Taken together, our study identifies a critical role for PD-1 in establishing central tolerance in autoreactive T cells that escape clonal deletion. It also sheds light on potential mechanisms of action of anti-PD-1 pathway immune checkpoint blockade and the development of immune-related adverse events.
科研通智能强力驱动
Strongly Powered by AbleSci AI